-
Abstract Number: 1649
Mycophenolate Mofetil and Cyclophosphamide Improve Health-Related Quality of Life in Patients with Systemic Sclerosis Who Participated in SLS II
-
Abstract Number: 1650
Baseline Skin Score, Older Age and CD34-selection Influence the Outcome of Autologous Stem Cell Transplantation for Systemic Sclerosis – Results of a Prospective Non-interventional Study from the European Society for Blood & Marrow Transplantation (EBMT)
-
Abstract Number: 1651
Multicenter Double-Blind, Proof-of-Concept, Randomized Placebo-Controlled Trial of Riociguat in Systemic Sclerosis-associated Digital Ulcers
-
Abstract Number: 1652
Anticentromere Antibody Levels and Isotypes Associate with Disease Severity in Systemic Sclerosis
-
Abstract Number: 1653
Efficacy and Safety of Romilkimab in Diffuse Cutaneous Systemic Sclerosis (dcSSc): A Randomized, Double-Blind, Placebo-Controlled, 24-week, Proof of Concept Study
-
Abstract Number: 1654
Esophageal Dilation and Other Clinical Factors Associated with Pulmonary Function Decline in Patients with Systemic Sclerosis
-
Abstract Number: 1655
Histologic Features Correlate with the Modified Rodnan Skin Score, Serum Inflammatory Markers, and Patient Reported Outcomes in Patients with Early, Diffuse Cutaneous Systemic Sclerosis
-
Abstract Number: 1656
Health-Related Quality of Life in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Impact of Lung Function on Patient-Reported Outcomes in a Randomized Phase III Trial
-
Abstract Number: 1657
Sarcopenia in Systemic Sclerosis
-
Abstract Number: 1658
Impact of Visceral Involvement in the Characterization and Prognosis of Patients Without Skin Involvement Classified as Systemic Sclerosis (SSc) According to 2013 ACR/EULAR Criteria in a Large Single Cohort
-
Abstract Number: 1659
Linaclotide for the Treatment of Gastrointestinal Symptoms in Systemic Sclerosis
-
Abstract Number: 1660
Serial Sublingual Videomicroscopy in Systemic Sclerosis Clinic: Are the Microcirculation Measurements Correlated with Gastrointestinal Symptoms?
-
Abstract Number: 1661
Circulating Cell Free DNA Released from Eosinophils Is a Practical Biomarker in Patients with Eosinophilic Granulomatosis with Polyangiitis
-
Abstract Number: 1662
Does PR3-ANCA+ Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss)Really Exist?
-
Abstract Number: 1663
Assessments of Quality of Life in Patients with Eosinophilic Granulomatosis with Polyangiitis
- « Previous Page
- 1
- …
- 111
- 112
- 113
- 114
- 115
- …
- 198
- Next Page »